ArticleCell death discovery2025

Targeting MTHFD2 alters metabolic homeostasis and synergizes with bortezomib to inhibit multiple myeloma.

Mingyuan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.